COVID-19

Increasing efforts have focused on treating COVID-19 among patients in rural areas, who can take advantage of traditional medicines.

Respiratory syntactical virus burdens quality of life and can lead to long-term health outcomes.

Multisystem inflammatory syndrome typically presents approximately 1 month after a COVID infection, occasionally resulting in cardiac complications in previously healthy children.

Individuals with the virus had an 81 times higher risk of dying in the first 3 weeks of infection, and that remained 5 times higher for up to 18 months, analysis shows.

Research showed that 600 hospital beds filled with patients with severe illness would be enough to reimplement (mask mandates to stop the spread of infection.

The therapeutic option is demonstrating favorable results for patients, despite the evolving nature of the SARS-CoV-2 virus.

Data from a recent survey reflect a resounding shift toward the role of pharmacies becoming sites for primary care.

Viral vector vaccines and a booster can protect maternal women against the Omicron variant of COVID-19, but the mRNA vaccine with a booster dose appears to offer the best protection.

Can the profession afford not to retain expanded job roles for technicians in a post-pandemic era?

The new strategy would propose annual COVID-19 vaccines, much like annual flu shots.

Antibodies help neutralize the virus, though the levels decrease at the 6-month mark, data indicate.

Educating patients, posting on social media, and countering misinformation are critical strategies.

18F-FDG PET/CT detects approximately 73% of tumor lesions, while 68Ga-FAPI finds approximately 94%.

Older patients received cancer treatment less frequently during the pandemic, as did patients covered by Medicaid.

Analysis indicates 4 peptides had significant or nearly significant seropositivity, all of which were associated with membrane and spike proteins of SARS-COVID-2.

COVID-19 infection was significantly associated with increased risks of several conditions, including loss of smell and taste, concentration, and memory impairment.

Recommendations vary based on age, first vaccination received, and time since the last dose.

Providers use "Kitchen Sink Approach" because cure proves elusive, symptomatic treatment is sketchy.

The risk of severe COVID-19 continues to outweigh the rare risk of post-vaccination myocarditis.

Relative risk calculations show that vaccinated individuals infected with the first Omicron subvariants of COVID-19 could have protection that lasts nearly 3 seasons.

An overview of current theses and research surrounding the pathogenesis, presentation, and treatment of COVID-19 in children.

Children who experienced COVID-19-induced multisystem inflammatory syndrome did not experience severe adverse reactions following COVID-19 vaccination.

Greater prevalence of hand eczema among health care professionals working in COVID-19 units linked to increased hand sanitation habits.

In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.

Intravenous tocilizumab (Actemra; Genentech) has been approved for the treatment of COVID-19 in individuals who are hospitalized and receiving systemic corticosteroids and supplemental oxygen.